Back

Association between endothelial dysfunction and pulmonary function in patients with post SARS-COV-2 infection

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Coronary artery disease / chronic coronary syndromes 2 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Celemi Mairim Vigil Lopez

Ensenada School of Health Sciences, Ensenada (Mexico)

7 More presentations in this session

Presentation thumbnail
Opportunistic cardiovascular risk stratification using coronary artery calcium scoring in patients with heart failure and atrial fibrillation without known coronary artery disease
Doctor A. Aguiar Neves (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Impact of insulin-treated diabetes on long-term mortality in patients with reduced left ventricular ejection fraction after myocardial infarction
Assistant Professor L. Savic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Impact of HFA-PEFF score in predicting outcomes of patients with coronary artery disease across the range of ejection fraction
Associate Professor S. Hwang (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Association between endothelial dysfunction and body composition in post-COVID-19 syndrome patients
Doctor A. Zurita Sandoval (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
The influence of CRP level on the no-reflow phenomenon followed by MACE in STEMI patients
Doctor X. Krasniqi (Pristina, XK)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary artery disease / chronic coronary syndromes 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Endothelial dysfunction in patients with post-COVID19 syndrome
thumbnail
Congress Presentation
Association between endothelial dysfunction and body composition in post-COVID-19 syndrome patients
thumbnail
Congress Presentation
Patients vaccinated against COVID-19 present better coronary flow, myocardial work and NTproNP levels than non-vaccinated at 4 months post COVID infection.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources